- Question from LeapY: There was some news about gefitinib (brand name: Iressa) in the treatment of metastatic disease. Is this drug available to be prescribed to patients with metastasis who haven't had this drug yet?
- Answers - Generosa Grana, M.D., F.A.C.P Gefitinib is an interesting drug that was thought to have great promise in a variety of cancers. It came on the market in the setting of advanced lung cancer and its activity was disappointing. It is commercially available, although I'm not sure how widely available it is because the supply has not really been supported. Despite the data presented at ASCO, I think it is a drug whose role in breast cancer is still not well defined.
The Ask-the-Expert Online Conference called Updates From the 2008 ASCO Annual Meeting featured Generosa Grana, M.D., F.A.C.P. and Carol Kaplan, M.D. answering your questions about the latest research advances on screening, treatment, side effects, and more.
Editor's Note: This conference took place in June 2008.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.